Aurora Spine earned Institutional Review Board approval to begin a multicenter study of its Dexa-C cervical interbody system, the devicemaker said March 2.
The Dexa-C system uses Aurora Spine’s patented color-coded implants which come in varyinh densities to match a patient’s bone density, according to a news release. The device is designed for anterior cervical discectomy and fusions.
Aurora Spine’s study will span up to 10 sites and enroll at least 40 single-level and 40-multi-level patients. Outcomes are expected to be measured at three months, six months and 12 months post-surgery.
The highest-paid CEOs at spine and orthopedic medtech companies saw total compensation of more than $20 million. Here is how…
Elon Musk’s brain-implant company, Neuralink, may soon have a new competitor in the market. Neurotechnology startup Precision Neuroscience has earned…
Alphatec CEO Patrick Miles earned about $6.2 million in total compensation, according to the company’s April 11 Securities and Exchange…
Comments are closed.